Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
August 2018, Vol 8, No 8
Venclexta Indicated for CLL or SLL, Alone or in Combination with Rituxan
FDA Approvals, News & Updates
August 2018, Vol 8, No 8
Read More ›
Keytruda Receives 2 New Indications: Metastatic Cervical Cancer and Relapsed Mediastinal Large B-Cell Lymphoma
FDA Approvals, News & Updates
August 2018, Vol 8, No 8
Read More ›
Bevacizumab plus Chemotherapy Approved for Several Types of Ovarian Cancer
FDA Approvals, News & Updates
August 2018, Vol 8, No 8
Read More ›
FDA Approves 2 New Biosimilars for Patients with Cancer
FDA Approvals, News & Updates
August 2018, Vol 8, No 8
Read More ›
Page 2 of 2
1
2